P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL

• David Ross,
• Devendra Hiwase,
• Steven Lane,
• Kirsty Sharplin,
• Agnes Yong,
• Yeung David,
• Dale Chappell,
• Cameron Durrant,
• Timothy Hughes,
• Daniel Thomas

Affiliations

David Ross

1 South Australian Health & Medical Research Institute, Adelaide, Australia

Devendra Hiwase

1 South Australian Health & Medical Research Institute, Adelaide, Australia

Steven Lane

2 Queensland Institute of Medical Research, Brisbane, Australia

Kirsty Sharplin

1 South Australian Health & Medical Research Institute, Adelaide, Australia

Agnes Yong

3 Royal Perth Hospital, Perth, Australia

Yeung David

1 South Australian Health & Medical Research Institute, Adelaide, Australia

Dale Chappell

4 Humanigen, Inc, Short Hills, NJ, United States

Cameron Durrant

4 Humanigen, Inc, Short Hills, NJ, United States

Timothy Hughes

1 South Australian Health & Medical Research Institute, Adelaide, Australia

Daniel Thomas

1 South Australian Health & Medical Research Institute, Adelaide, Australia